Discover Manus, the world’s first fully autonomous AI agent that can perform complex tasks independently without human guidance.

In IDB, macrophages, a type of immune cell begins producing excessive levels of pro-inflammatory cytokines. These proteins then stick to macrophage receptors which triggers them to produce even more of this inflammatory protein. But UC San Diego researchers can break that cycle with a microrobot.

In previous experiments, UC San Diego researchers delivered drugs with microrobots, most notably in the lungs, and succeeded in minimizing the drug’s side effects. For the IBD study, however, they didn’t even need to use a drug.

The U.S. DARPA has launched the USX-1 Defiant, a 240-metric-ton unmanned surface vessel (USV) designed for fully autonomous naval missions.

A robotic labor force.

Engineering companies in China have begun the process of starting full-scale mass production of humanoid robots in anticipation of a commercial boom in 2025. Companies such as Shanghai Zhiyuan Innovation Technology (AgiBot) and Shanghai Kepler Robot Company have already been testing the robots to optimize performance while reducing production costs.

New therapies for managing aging could emerge from research into a new gene, which scientists have identified as a key driver of degeneration.

Age-related diseases are strongly linked to inflammation which, when chronic, albeit low-grade, contributes to conditions such as cardiovascular disease, diabetes, neurodegeneration, and sarcopenia, significantly impacting health and longevity.

In a study published in Nature Communications, Dr. Ildus Akhmetov, a geneticist at Liverpool John Moores University’s School of Sport and Exercise Sciences, along with colleagues from Italy, Switzerland, and the Netherlands, uncovered groundbreaking insights into the role of the Ectodysplasin A2 Receptor (EDA2R) in this process.

A groundbreaking cancer ‘vaccine’ developed by a Yale University scientist has reversed the disease in nine patients.

All patients enrolled in the study between March 2019 and September 2021 were free from kidney cancer at the three-year follow-up in July 2023, marking a major milestone.

The type of kidney cancer they had — stages three and four clear cell renal cell carcinoma (ccRCC) — kills between 85 and 90 percent of patents.

UT Dallas researchers have identified the cause of LiNiO₂ battery degradation and developed a structural reinforcement method that could enable its commercial use in longer-lasting lithium-ion batteries.

Lithium nickel oxide (LiNiO₂) is a promising material for next-generation lithium-ion batteries with longer lifespans. However, its commercialization has been hindered by degradation after repeated charging cycles.

Researchers at the University of Texas at Dallas have identified the cause of this breakdown and are testing a solution that could overcome a major obstacle to its widespread use. Their findings were recently published din the journal Advanced Energy Materials.

Gladstone researchers create a drug that replicates the cellular effects of low-oxygen therapy to treat inherited mitochondrial diseases.

For most people, living at high altitudes—where oxygen levels are lower than at sea level—can offer health benefits, such as reduced rates of heart disease and improved endurance. However, for individuals with inherited mitochondrial diseases, who often do not survive beyond childhood, low-oxygen environments like those at high elevations could be life-saving, potentially prolonging their lifespan and alleviating symptoms.

Now, researchers at Gladstone Institutes have developed a drug that replicates the effects of low-oxygen exposure. In mice with Leigh Syndrome—the most common childhood mitochondrial disease—the drug, called HypoxyStat, extended lifespan more than threefold and reversed brain damage and muscle weakness, even when administered in the disease’s late stages.

A small number of people report chronic symptoms after receiving COVID-19 shots. A new study provides clues for further research.

Humans and certain animals appear to have an innate capacity to learn relationships between different objects or events in the world. This ability, known as “relational learning,” is widely regarded as critical for cognition and intelligence, as learned relationships are thought to allow humans and animals to navigate new situations.

Researchers at ML Collective in San Francisco and Columbia University have conducted a study aimed at understanding the biological basis of relational learning by using a particular type of brain-inspired artificial neural network. Their work, published in Nature Neuroscience, sheds new light on the processes in the brain that could underpin relational learning in humans and other organisms.

“While I was visiting Columbia University, I met my co-author Kenneth Kay and we talked about his research,” Thomas Miconi, co-author of the paper, told Medical Xpress.